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atheter Ablation of Atrial
ibrillation: What Is the Best
echnique for Achieving a High
ure Rate With Acceptable Risk?*
regory K. Feld, MD
an Diego, California
ince the first report of radiofrequency catheter ablation
uring atrial fibrillation (AF) nearly a decade ago (1),
umerous techniques have evolved, from linear ablation to
odify the reentrant substrate for AF (1,2), to electrical
solation of pulmonary vein(s) to eliminate triggers of AF
3–5), to hybrid approaches of circumferential ablation
round and between the pulmonary veins and mitral valve
nnulus to modify both the triggers and substrate for AF
6,7). With each new approach, success rates for curing
aroxysmal and chronic AF have improved, reaching as high
s 88% and 68%, respectively, in recent publications (6,7).
See page 2044
n this issue of the Journal, Nademanee et al. (8) describe yet
nother approach for radiofrequency catheter ablation of
F, targeting complex fragmented atrial electrograms
CFAEs) identified by three-dimensional contact mapping
CARTO EP Navigation System, Biosense Webster, Inc.,
iamond Bar, California) of the left atrium (LA) and right
trium (RA). Study end points were elimination of all
FAEs, short-term termination and prevention of the
einduction of AF, and long-term prevention of AF recur-
ence. Included were 64 patients with chronic AF (CAF)
nd 57 with paroxysmal AF (PAF), 79 of whom had
tructural heart disease. The mean left atrial (LA) dimen-
ion was 42  6 mm. The distribution of CFAEs was
ariable, with some patients having CFAEs in one location,
ome in two locations, and some in three or more locations,
ncluding the inter-atrial septum, pulmonary veins, LA roof,
nd mitral valve annulus. Ablation of CFAEs resulted in the
ermination of AF in 115 of 121 patients (in conjunction
ith ibutilide infusion in 32) and prevented the recurrence
f arrhythmia at one-year follow-up in 92 of 121 (76%)
atients after the first procedure and in 110 of 121 (91%)
fter a second procedure. The majority with recurrent
rrhythmia had atrial flutter (typical or atypical) requiring
epeat ablation. The mechanism by which ablation of
FAEs prevents recurrence of AF is not entirely delineated,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Division of Cardiology, Cardiac Electrophysiology Program, Universityif California, San Diego, California.ut in view of the high success rate for CAF, further
nvestigation of this ablation approach seems warranted.
his editorial will review the potential mechanisms by
hich ablation of CFAEs cures AF and compare the results
ith other approaches.
The electrophysiological mechanisms underlying AF
ave been extensively investigated in the past and have
evealed evidence for both focal electrical activity triggering
F (3) and reentrant activity (multiple wavelet re-entry)
aintaining AF (9). The predominant site of focal electrical
ctivity triggering AF is the pulmonary veins (3–5,10). The
lectrophysiological mechanism of pulmonary vein (PV)
lectrical activity is not clear, although abnormal automa-
icity, triggered activity, and micro-reentry all have been
ostulated. Regardless of the mechanism, such focal elec-
rical activity results either in single premature atrial depo-
arizations that trigger AF or continuous atrial depolariza-
ion that triggers and sustains AF. There is evidence that
oth parasympathetic autonomic activity and stretch as a
esult of increased LA pressure may play a role in the
evelopment of focal electrical discharges originating in the
Vs, observations that support either abnormal automaticity
r triggered activity as a potential mechanism (11,12).
ecent studies have also demonstrated the abnormal short-
ning of the effective refractory period and depressed con-
uction velocity in PVs that could support microreentry as a
echanism of focal electrical activity (13).
In contrast, multiple wavelet re-entry occurs throughout
he LA and RA during sustained AF (14). Multiple wavelet
e-entry is due in part to the abnormal shortening of atrial
efractoriness and the depression of conduction velocity,
hich results in the increased dispersion of atrial refracto-
iness and shortening of wavelength, both of which are
ritical for initiation and maintenance of re-entry (15).
apping studies during sustained AF suggest that re-entry
ay not be random but involve periodically repeating
avefronts related to anatomical or functional areas of
onduction block or delay (14). Parasympathetic autonomic
timulation and atrial stretch, which increase dispersion of
trial refractoriness (16) and shorten atrial refractory period,
espectively (17), also may promote multiple wavelet re-
ntry.
From the clinical perspective, PAF appears to result from
ocal triggering in most cases. Having recognized this
henomenon during early attempts at linear ablation of AF,
umerous studies have now confirmed the efficacy of elec-
rical isolation of PVs to cure AF (3–5). Electrical record-
ngs using a circular catheter (LASSO, Biosense Webster,
nc.) positioned at the PV ostium allow the identification of
rrhythmogenic PV musculature, so-called PV potentials,
esponsible for triggering AF (3–5), which can be electri-
ally isolated from the LA by map-guided ablation of LA to
V connections (3–5). The long-term success of this ap-
roach ranges from 60% to 80%, the best results occurring
n patients without structural heart disease. The complica-
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June 2, 2004:2054–6 Editorial Commention rate is relatively low, but there is risk of PV stenosis (1%
o 3%), which in symptomatic cases may require balloon
ilation and/or stenting (3–5). Consequently, an alternative
pproach has recently been described that uses three-
imensional contact mapping to create LA linear lesions
ncircling the right and left PVs and connecting these
ncircling lesions to each other and to the mitral valve
nnulus (6,7). Linear ablation, although it may not always
solate the PVs, results in even higher success rates, elimi-
ating PAF in up to 88% of patients (6,7). Furthermore, by
blating strictly in the atrium, the risk of PV stenosis is
educed (6,7).
Chronic AF, although potentially triggered by focal
lectrical activity, typically is sustained by multiple wavelet
e-entry (9–13). Clinically, CAF more often is associated
ith structural heart disease and is by definition long
tanding compared with PAF. Increases in LA pressure
ssociated with structural heart disease and a prolonged
uration of AF both produce LA dilation and are associated
ith development of abnormal underlying atrial electro-
hysiology, a process called electrical remodeling (17–19).
lectrical remodeling, although initially reversible with the
reatment of underlying heart disease and the termination of
F, eventually produces irreversible structural changes and
lectrophysiological abnormalities that sustain AF. Conse-
uently, simple PV isolation is less effective for CAF, with
ong-term success in only 15% to 20% of patients (4,5). In
ontrast, LA linear ablation results in cure of CAF in up to
8% of patients (6,7). The greater success of linear ablation
n CAF is likely due to modulation of both abnormal atrial
ubstrate and PV triggers. In addition, it is possible that
inear ablation may reduce LA parasympathetic autonomic
ctivity, producing a salutary effect on AF (6,7).
This new approach to ablate AF targeting CFAEs
roposed by Nademanee et al. (8) contains elements of both
V isolation and linear ablation in that it ablates a relatively
xtensive amount of atrial tissue containing both areas with
low conduction or block and areas of focal electrical
ischarge. Thus, the ablation of CFAEs may eliminate
bnormal atrial substrate capable of multiple wavelet re-
ntry known to sustain AF as well as atrial tissue capable of
riggering AF. This approach may also modulate parasym-
athetic autonomic activity, minimizing its role in initiating
r sustaining AF. Thus, the success of ablation of CFAEs in
atients with CAF, which is comparable with that of LA
inear ablation (6,7), may not be unexpected. However, it is
lear from the figures and methods (8) that this new
pproach is not as likely to electrically isolate the PVs as is
inear ablation (6,7). This may explain why the long-term
uccess of ablation of CFAEs in patients with PAF (8) is
ot quite as high as that for linear ablation (6,7).
There may be several limitations of the ablation approach
escribed by Nademanee et al. (8). Although the number of
oints required to generate the anatomical and voltage maps
s not stated (8), extremely detailed contact mapping may be
eeded to ensure that all areas with CFAEs requiringblation are identified, because insufficient mapping could
dversely affect long-term success. With older contact map-
ing systems, the acquisition of large numbers of points
equires a significant amount of time. Fortunately, newer
ontact and non-contact mapping systems may allow more
apid acquisition using multi-polar catheters to create high-
ensity maps and locate CFAEs. In addition, there was a
omplication rate of nearly 5% in this study (8), including
troke, cardiac tamponade, and AV block. This could be in
art related to the extensive ablation performed and conse-
uently may limit widespread acceptance of this approach to
blate AF.
With the recent shift in favor of LA ablation over PV
solation to cure AF, new ablation techniques such as that
escribed by Nademanee et al. (8) are of interest but will
equire careful study to safely reproduce their results. Such
tudies should evaluate these new ablation techniques,
hich may have differing effects on atrial substrate and focal
riggers, in both PAF and CAF, because of their potentially
ifferent arrhythmia mechanisms. Finally, special attention
hould be given to the relative efficacy, safety, and ease of
erforming each ablation technique to maximize success
nd minimize complications in patients with either CAF or
AF.
eprint requests and correspondence: Dr. Gregory K. Feld,
CSD Medical Center, 200 West Arbor Drive, San Diego,
alifornia 92103. E-mail: gfeld@ucsd.edu.
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